Zobrazeno 1 - 10
of 379
pro vyhledávání: '"CJ Bulpitt"'
Autor:
CJ Bulpitt, NS Beckett
Publikováno v:
Disease Management and Health Outcomes. 5:45-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e41d3930e3259c4605ecc3efe04a1407
https://doi.org/10.2165/00115677-199905991-00005
https://doi.org/10.2165/00115677-199905991-00005
Autor:
Harry Wesseling, Cj Bulpitt, Jf May, Cm Hawkins, Ae Fletcher, Bs Tenberge, TK Havinga, F. H. Schuurman, E Vanderveur
Publikováno v:
Journal of Hypertension, 8(5), 463-466. LIPPINCOTT WILLIAMS & WILKINS
A randomized double-blind study lasting 2 months was performed with either 25 mg captopril twice a day or 50 mg atenolol once a day in 125 patients with established diastolic hypertension (diastolic blood pressure greater than 95 mmHg) identified dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b278e00bf9469803e78df52cfaff471
https://doi.org/10.1097/00004872-199005000-00011
https://doi.org/10.1097/00004872-199005000-00011
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::40fef1f4b4fadab2a83d8e9dbcac32a2
https://pubmed.ncbi.nlm.nih.gov/8510097
https://pubmed.ncbi.nlm.nih.gov/8510097
Publikováno v:
Southern Medical Journal. 92:733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2517f83d1b0d3e7bf05deeedcefe0c60
https://doi.org/10.1097/00007611-199907000-00024
https://doi.org/10.1097/00007611-199907000-00024
Publikováno v:
Age and Ageing. 24:P23-P23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3888c9b084ffbffa249464b2585579f
https://doi.org/10.1093/ageing/24.suppl_1.p23-c
https://doi.org/10.1093/ageing/24.suppl_1.p23-c
Publikováno v:
Reviews in Clinical Gerontology; May2005, Vol. 15 Issue 2, p71-82, 12p
Publikováno v:
International Journal of Epidemiology; Apr2005, Vol. 34 Issue 2, p276-283, 8p
Publikováno v:
British Journal of Clinical Pharmacology. 9:233-237
1 Labetalol has been compared with propranolol in a double-blind, double-dummy study of 24 patients with mild or moderate essential hypertension. 2 Two patients were unable to tolerate propranolol and five labetalol, because of symptom side effects;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a2cb835800a1cb991d0270e0c0ae3a
https://doi.org/10.1111/j.1365-2125.1980.tb04832.x
https://doi.org/10.1111/j.1365-2125.1980.tb04832.x
Autor:
AE Fletcher, CJ Bulpitt
Publikováno v:
British journal of clinical pharmacology. 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc027802c35ee2a206ff6629efdad53
https://pubmed.ncbi.nlm.nih.gov/3756060
https://pubmed.ncbi.nlm.nih.gov/3756060
Autor:
CJ Bulpitt
1 The 5 year survival of hypertensive patients in several studies was reviewed to demonstrate the adverse effects of increasing age, being male, having a higher untreated blood pressure of severe retinal changes. 2 The decrease in survival with incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac1ac8c9a1847bc2c3e323e9e227b7c
https://europepmc.org/articles/PMC1401775/
https://europepmc.org/articles/PMC1401775/
